ZENAS BIOPHARMA INC (ZBIO) Stock Analyst Ratings
NASDAQ:ZBIO - Nasdaq - US98937L1052 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to ZBIO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.47. This target is 314.69% above the current price.
ZBIO was analyzed by 11 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ZBIO.
In the previous month the buy percentage consensus was at a similar level.
ZBIO was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-04 | Wolfe Research | Initiate | Outperform |
| 2024-12-16 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-12-03 | Guggenheim | Reiterate | Buy |
| 2024-10-08 | Guggenheim | Initiate | Buy |
| 2024-10-08 | Morgan Stanley | Initiate | Overweight |
| 2024-10-08 | Citigroup | Initiate | Buy |
| 2024-10-08 | Jefferies | Initiate | Buy |